Lung Cancer Clinical Trial

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Summary

To study the efficacy and tolerability of gemcitabine/platinum chemotherapy in non small cell lung cancer

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically of cytologically confirmed non small cell lung cancer
No prior chemotherapy or radiation
No prior malignancy

Exclusion Criteria:

Pregnant or breastfeeding
Serious concomitant systemic disorder

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

70

Study ID:

NCT00191230

Recruitment Status:

Completed

Sponsor:

Eli Lilly and Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chapel Hill North Carolina, , United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

70

Study ID:

NCT00191230

Recruitment Status:

Completed

Sponsor:


Eli Lilly and Company

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider